Laura E. Moreno-Luna

629 total citations
10 papers, 471 citations indexed

About

Laura E. Moreno-Luna is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Laura E. Moreno-Luna has authored 10 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Laura E. Moreno-Luna's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease and Transplantation (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Laura E. Moreno-Luna is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease and Transplantation (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Laura E. Moreno-Luna collaborates with scholars based in United States, Mexico and Italy. Laura E. Moreno-Luna's co-authors include Lewis R. Roberts, Sreekumar Raghavakaimal, John J. Poterucha, Charles B. Rosen, Kenneth P. Batts, Michael Charlton, Lawrence J. Burgart, Walter K. Kremers, Russell H. Wiesner and Gregory J. Gores and has published in prestigious journals such as Hepatology, Journal of Hepatology and American Journal of Clinical Pathology.

In The Last Decade

Laura E. Moreno-Luna

10 papers receiving 465 citations

Peers

Laura E. Moreno-Luna
K. Thrum Germany
Martin J. Dib United States
F Meriggi Italy
Olcay Çubukçu United States
K. Thrum Germany
Laura E. Moreno-Luna
Citations per year, relative to Laura E. Moreno-Luna Laura E. Moreno-Luna (= 1×) peers K. Thrum

Countries citing papers authored by Laura E. Moreno-Luna

Since Specialization
Citations

This map shows the geographic impact of Laura E. Moreno-Luna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Moreno-Luna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Moreno-Luna more than expected).

Fields of papers citing papers by Laura E. Moreno-Luna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Moreno-Luna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Moreno-Luna. The network helps show where Laura E. Moreno-Luna may publish in the future.

Co-authorship network of co-authors of Laura E. Moreno-Luna

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Moreno-Luna. A scholar is included among the top collaborators of Laura E. Moreno-Luna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Moreno-Luna. Laura E. Moreno-Luna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Brown, Andrew, Marco Massani, Whitney Townsend, et al.. (2022). TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis. Cancer Medicine. 12(3). 2590–2599. 39 indexed citations
2.
Martínez‐López, Erika, et al.. (2015). Influence of ApoE and FABP2 polymorphisms and environmental factors in the susceptibility to gallstone disease. Annals of Hepatology. 14(4). 515–523. 26 indexed citations
3.
Román, Sonia, Nora A. Fierro, Laura E. Moreno-Luna, & Arturo Panduro. (2013). Hepatitis B Virus Genotype H and Environmental Factors Associated to the Low Prevalence of Hepatocellular Carcinoma in Mexico. Journal of Cancer Therapy. 4(2). 367–376. 19 indexed citations
4.
Moreno-Luna, Laura E., Ju Dong Yang, William Sánchez, et al.. (2012). Efficacy and Safety of Transarterial Radioembolization Versus Chemoembolization in Patients With Hepatocellular Carcinoma. CardioVascular and Interventional Radiology. 36(3). 714–723. 113 indexed citations
5.
Moreno-Luna, Laura E., James C. Andrews, & Lewis R. Roberts. (2009). The Clinical Value of Radioembolization in the Treatment of Inoperable Liver Cancer. 5(1). 65–65. 3 indexed citations
6.
Moreno-Luna, Laura E., James C. Andrews, & Lewis R. Roberts. (2008). The Clinical Value of Radioembolisation in the Treatment of Inoperable Liver Cancer. European Oncology & Haematology. 4(2). 66–66. 3 indexed citations
7.
Moreno-Luna, Laura E., Denise M. Harnois, Konstantinos Lazaridis, et al.. (2008). 395 SURVIVAL OF PATIENTS RECEIVING YTTRIUM-90 MICROSPHERES VS CHEMOEMBOLIZATION FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA. Journal of Hepatology. 48. S153–S153. 1 indexed citations
8.
Fritcher, Emily G. Barr, Benjamin R. Kipp, Jeffrey M. Slezak, et al.. (2007). Correlating Routine Cytology, Quantitative Nuclear Morphometry by Digital Image Analysis, and Genetic Alterations by Fluorescence In Situ Hybridization to Assess the Sensitivity of Cytology for Detecting Pancreatobiliary Tract Malignancy. American Journal of Clinical Pathology. 128(2). 272–279. 58 indexed citations
9.
Moreno-Luna, Laura E., Óscar Arrieta, Braulio Martínez‐Benítez, et al.. (2005). Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma. BMC Cancer. 5(1). 142–142. 49 indexed citations
10.
Raghavakaimal, Sreekumar, Kenneth P. Batts, Laura E. Moreno-Luna, et al.. (2000). Early Identification of Recipients With Progressive Histologic Recurrence of Hepatitis C After Liver Transplantation. Hepatology. 32(5). 1125–1130. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026